Economic Stimulus Resources
Information / Additional Resources
COVID-19 and Economic Stimulus-Related Funding Opportunities
In these challenging times there are many opportunities for NAU researchers, scholars, and collaborators to contribute positively to addressing the COVID-19 pandemic and aspects of its aftermath. To help make you aware of the relevant funding opportunities for funding related to the COVID-19 pandemic, or subsequently for efforts related to the stimulus aimed at helping economic recovery, the Office of Sponsored Projects (OSP) is collecting program announcements and will be adding to this page as they become available. Please contact Adam.Bradley@nau.edu to report additional opportunities.
Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to provide an expedited funding mechanism for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is issuing this FOA in response to the declared public health emergency issued by the Secretary, HHS, for 2019 Novel Coronavirus (COVID-19).
Open Date (Earliest Submission Date): 4/30/2020
Applications will be accepted on a rolling basis, beginning on 04/30/2020.
High Performance Computing for Energy Innovation (HPC4EI)
HPC4EI conducts two regular solicitations annually, one in the fall and one in the spring. The spring solicitation will target qualified industry partners to participate in short-term, collaborative projects with the Department of Energy (DOE) National Laboratories that address key manufacturing challenges by applying modeling, simulation, and data analysis. The solicitation will encourage applicants to partner with universities and non-profit organizations located within federally designated Opportunity Zones and/or Historically Black Colleges and Universities (HBCUs).
Eligibility for the program is limited to entities that manufacture products or operate systems in the U.S. for commercial applications and organizations that support them. Selected projects will be awarded up to $300,000 to support computing cycles and work performed by DOE National Laboratories, universities, and non-profit partners. All DOE National Laboratories are eligible to participate. The industry partner must provide a participant contribution of at least 20% of the total project funding.
DOE’s Advanced Manufacturing Office (AMO), within the Office of Energy Efficiency and Renewable Energy, is the primary sponsor of the High Performance Computing for Manufacturing program. AMO partners with private and public stakeholders to advance innovation in U.S. manufacturing and promote American economic growth and energy security.
AI for Health
On January 29, 2020, Microsoft announced the launch of AI for Health, an initiative to advance the health of people and communities around the world. This five-year commitment was created to empower nonprofits, researchers and organizations with AI and data science tools.
Application Deadline: June 15, 2020
Distance Learning and Telemedicine Grants
The U.S. Department of Agriculture’s Distance Learning and Telemedicine program has opened an additional filing window for a grant opportunity designed to help rural communities leverage telecommunications for distance learning and telemedicine with a minimum grant amount of $50,000 and a maximum of $1,000,000 for qualifying activities in rural areas. This window also makes available up to $25 million received from the CARES Act. While the CARES Act requires these funds be used to prevent, prepare for, and respond to coronavirus, the agency believes that all DLT projects already serve that purpose. As a result, while not required, applicants are encouraged to identify specific ways in which their application addresses COVID-19. The official announcement is available through the USDA’s website.
Application Deadline: July 13, 2020
U.S. Department of Justice: FY 2020 Coronavirus Emergency Supplemental Funding Program
The Coronavirus Emergency Supplemental Funding (CESF) Program will provide funding to assist eligible states, local units of government, and tribes in preventing, preparing for, and responding to the coronavirus.
Allowable projects and purchases include, but are not limited to, overtime, equipment (including law enforcement and medical personal protective equipment), hiring, supplies (such as gloves, masks, sanitizer), training, travel expenses, and addressing the medical needs of inmates in state, local, and tribal prisons, jails, and detention centers.
Application Deadline: 11:59 p.m. eastern time on May 29, 2020
NSF Funding Opportunities for Research on the Impact of COVID19 on Undergraduate STEM Education
NSF has encouraged submission of proposals related to Coronavirus Disease 2019 (COVID-19), as described in the Dear Colleague Letter.
The Department of Undergraduate Education (DUE) is specifically interested in research on the impact of the COVID-19 outbreak on undergraduate education. The outbreak has altered undergraduate education in unforeseen ways, including forcing temporary closures and unplanned switches to online classes. DUE thinks that research about the impacts of such responses on students and educators could provide important new knowledge about STEM learning, virtual learning environments, the impact of stress on learning, and many other important topics.
If you are interested in pursuing such research please consider submitting a proposal to any relevant funding programs including the Improving Undergraduate STEM Education (IUSE): EHR program, the IUSE:HSI program, the S-STEM program, the ATE program, the Noyce Program, and the ECR Core research program. (See https://www.nsf.gov/funding/programs.jsp?org=DUE)
Alternatively (or in addition), if you have an urgent research need or opportunity, you may consider submitting proposals via the following funding mechanisms:
1. Submit a Rapid Response Research (RAPID) proposal.
See Chapter II.E.1 of the NSF Proposal and Award Policies and Procedures Guide
2. Request supplemental support for your existing award.
See Chapter VI.E.4 of the NSF Proposal and Award Policies and Procedures Guide
3. Organize a conference or workshop.
See Chapter II.E.7 of the NSF Proposal and Award Policies and Procedures Guide
Possible topics of interest for these funding mechanisms include, but are not limited to, research on the effectiveness of switching from an in-person to a completely online educational format and research on how the outbreak affects student attitudes, interests, and performance in STEM.
Important: You should contact a program officer to explore whether your needs might be appropriate for funding via the RAPID, Supplemental Support, or Conference mechanisms. A list of DUE staff is available at https://www.nsf.gov/staff/staff_list.jsp?org=DUE&from_org=DUE.
Hanover Research Grant Alerts: COVID-19 & Higher Education Research (Week of 4/13 to 4/17)
For the next several weeks, Hanover Research Grant Alerts updates will lead off with a comprehensive overview of the funding landscape pertaining to the COVID-19 response effort.
Hanover is closely monitoring developments surrounding COVID-19 and how it has and may continue to impact the education community. This resource center provides key facts, resources, and potential responses to this rapidly evolving situation. The Hanover Research dedicated COVID-19 support email (covid19-support@hanoverresearch.com) can be used to ask any questions related to COVID-19.
Overview of COVID-19 Senate Stimulus Bill (CARES Act) Accordion Closed
The White House and Senate recently agreed to a $2 trillion stimulus bill to ease the economic impact during the COVID-19 epidemic. Passed by the House on March 27, the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) includes, among other initiatives:
- $500 billion in loans for cities, states and businesses;
- $349 billion in loans for small businesses (i.e., those with fewer than 500 employees);
- $150 billion in emergency aid for state, local, and tribal governments;
- $117 billion for hospitals and health care providers; and
- $31 billion for an Education Stabilization Fund for states, school districts and institutions of higher education for costs related to the coronavirus.
Department of Education Accordion Closed
According to the CARES Act, the Department of Education will receive $30.75 billion for an Education Stabilization Fund for states, school districts, and institutions of higher education for costs related to the coronavirus. The allotted funding is apportioned as follows: 9.8% for the Governor’s Relief Fund, 43.9% for elementary and secondary education, and 46.3% for higher education.
Governor’s Relief Fund
Governors in each state will receive a share of $3 billion for emergency support grants. Funds are allocated to state governors according to the formula: 60% based on the size of the population aged 5–24, 40% on the basis of relative total population. Governors may use funds for emergency support to LEAs; emergency support to IHEs; or to support any other education-related entity that has been impacted by the coronavirus.
Elementary and Secondary Education
For elementary and secondary education, $13.5 billion will be available for formula grants to states, 90% of which will be allotted in the same proportion that each state received funding under ESSA Title IA in the most recent fiscal year (2019-2020). The remaining 10% may be reserved for emergency needs by the state.
LEAs may use funding for any activity authorized by the Vento Homeless Assistance Act, as well as for the following activities:
- Coordination of preparedness and response efforts of local educational agencies public health departments;
- Providing principals and other school leaders with the resources necessary to address the needs of their individual schools;
- Activities to address the unique needs of low-income children or students, children with disabilities, and other vulnerable populations;
- Developing and implementing procedures and systems to improve the preparedness and response efforts of local educational agencies;
- Training and professional development for staff of the local educational agency on sanitation and minimizing the spread of infectious diseases;
- Purchasing supplies to sanitize and clean facilities;
- Planning for and coordinating during long-term closures;
- Purchasing educational technology;
- Providing mental health services;
- Planning and implementing activities related to summer learning and supplemental after-school programs; and
- Other activities necessary to maintain operations.
Finally, ED is allowing the waiving of testing requirements and reporting obligations of academic standards for state and local education agencies.
Higher Education
For higher education, $14.25 billion will be available for to prevent, prepare for, and respond to the coronavirus. This funding will be allotted to each IHE according to the relative share of full-time equivalent enrollment of Federal Pell Grant recipients (75% on its share of Pell FTE students, and 25% on non-Pell FTE students).
Funds may be used to defray expenses for lost revenue, technology costs associated with adopting distance education, and grants to students for health care, food, housing, course materials, and related needs. Notably, funding cannot be used to pay contractors for pre-enrollment recruitment activities; for endowments; or for capital outlays associated with facilities for athletics, secretarial instruction, or religious worship. At least half of funds must be used for emergency financial aid grants to students due to coronavirus related disruption.
In addition, for 2019-2020 and 2020-2021, ED will waive the obligation for IHEs to match federal grants for campus-based aid programs with an equivalent amount (for non-profit institutions only). Institutions will also be permitted to allocate funds previously assigned to work-study programs to supplemental grants. IHEs will be permitted to award additional emergency financial aid funds to students that have been impacted by the coronavirus, and will also be allowed to issue work-study payments as lump sums to students who are not able to work due to closures. ED is also allowing for the waiving or modification of current allowable uses of funds for institutional grant programs, and will waive certain outcome requirements for grant programs for HBCUs and other MSIs.
Timeline
The CARES Act states (for the Education Stabilization Fund) that: “The Secretary shall issue a notice inviting applications not later than 30 days of enactment of this Act and approve or deny applications not later than 30 days after receipt,” indicating an announcement in April with a due date in May. For the Governor’s Relief Fund, grants will be awarded “to the governor of each state with an approved application.” For elementary and secondary education, grants are awarded “to each state educational agency with an approved application.” For higher education, the CARES Act states that funding will be awarded directly to IHEs (without a timeline).
Other Federal Stimulus Accordion Closed
In addition to the education stimulus listed above, many other federal agencies and departments are receiving funding through the CARES Act. While some funds are clearly earmarked for internal costs (e.g., operations, payroll) and are therefore not listed below, other funding will be at least partially distributed through external grants and/or contracts. The most likely candidates for external funding are listed below. We will provide updates on external grant competitions as more data becomes available.
Department of Health and Human Services
- Administration for Community Living: $955M for aging and disability services programs, of which $50M is allotted for aging and disability resource centers.
- Assistant Secretary for Preparedness and Response: $127B, including a new program to provide grants to hospitals and health providers to assist with unreimbursed health care related expenses or other loss of revenue due to the coronavirus. $27B will go to the Biomedical Advanced Research and Development Authority (BARDA) to support research and development of vaccines, therapeutics, and diagnostics to prevent or treat the effects of the novel coronavirus.
- Centers for Disease Control and Prevention: $4.3B to support federal, state, and local public health agencies, including:
- $1.5B for purchase of personal protective equipment, laboratory testing, contact tracing, infection control, and related activities;
- $1.5B to support quarantine efforts, purchase and distribution of diagnostic test kits, support for laboratory testing, workforce training programs, and related activities
- $500M for global disease detection and emergency response;
- $500M for public health data surveillance and modernizing infrastructure; and
- $300M for the Infectious Diseases Rapid Response Reserve Fund, to address immediate response activities during outbreaks.
- Centers for Medicare & Medicaid Services: $200M, of which $100M is allotted for necessary expenses of the survey and certification program, prioritizing nursing home facilities in localities with community transmission of coronavirus.
- Food and Drug Administration: $80M for work on medical counter-measures, therapies, vaccines, and research.
- Health Resources and Services Administration: $275M, including $90M for Ryan White HIV/AIDS programs and $185M to support rural hospitals, telehealth, and poison control centers. Notably, the CARES Act also renews various existing HRSA health professions workforce programs, such as the Geriatrics Workforce Enhancement Program and Nursing Workforce Diversity program, which were reauthorized at roughly similar funding levels.
- Indian Health Services: ~$1B billion for public health support, electronic health record modernization, telehealth and other information technology upgrades, Purchased/Referred Care, Catastrophic Health Emergency Fund, Urban Indian Organizations, Tribal Epidemiology Centers, Community Health Representatives, and other activities to protect the safety of patients and staff.
- National Institutes of Health: $945M to support research on the coronavirus’s transmission and the natural history of infection, new approaches to diagnosing the disease, and developing countermeasures. Breakdown by IC is as follows:
- National Heart, Lung, and Blood Institute: $103.4M
- National Institute of Allergy and Infectious Diseases: $706M, of which $156M will be provided for the study of, construction of, demolition of, renovation of, and acquisition of equipment for, vaccine and infectious diseases research facilities of or used by NIH (leaving $550M for possible external funding).
- National Institute of Biomedical Imaging and Bioengineering: $60M
- National Library of Medicine: $10M
- NIH Office of the Director: $30M
- Substance Abuse and Mental Health Services Administration: $425M for health surveillance and program support, of which $250M is allotted for the Certified Community Behavioral Health Clinic Expansion Grant program, and $50M is allotted for suicide prevention programs.
Other Federal Entities
- Department of Agriculture: $25M in additional funding for the Distance Learning, Telemedicine, and Broadband Program.
- Department of Commerce, Economic Development Administration: $1.5B for economic development assistance programs.
- Department of Commerce, National Institute of Standards and Technology: $6M for Scientific and Technical Research And Services to support continuity of operations, including measurement science to support viral testing and biomanufacturing, $60M for Industrial Technology Services, and $10M for the National Network for Manufacturing Innovation to support development and manufacturing of medical countermeasures and biomedical equipment and supplies.
- Department of Commerce, National Oceanic and Atmospheric Administration: $20M for operations, research, and facilities.
- Department of Defense, Defense Health Program: $415M for research, development, testing and evaluation.
- Department of Energy: $99.5M to prevent, prepare for, and respond to coronavirus for necessary expenses related to providing support and access to scientific user facilities in the Office of Science and National Nuclear Security Administration, including equipment, enabling technologies, and personnel associated with the operations of those scientific user facilities.
- Department of Housing and Urban Development, Community Development Block Grant: $5B for states, counties, and cities, including for the expansion of community health facilities, child care centers, food banks, and senior services. $2B will be allocated to states according to the 2020 CDBG formula, $1B will help states to support a coordinated response across their communities, and $2B will help states and units of local government, cities, and counties based on coronavirus risk to economic and housing issues.
- Department of Labor, Employment and Training Administration: $345M for training and employment services. In addition, existing DOL Workforce Innovation Opportunity Act funds reserved by a Governor for program year 2019 for statewide activities that remain unobligated may be used for statewide rapid response activities.
- Environmental Protection Agency: $1.5M for research methods on reducing the risks from environmental transmission of the coronavirus via contaminated services or materials.
- Institute of Museum and Library Services: $50M for grants to states, territories, and tribes to expand digital network access, purchase internet accessible devices, and provide technical support services.
- National Endowment for the Arts: $75M to be distributed in grants.
- National Endowment for the Humanities: $75M to be distributed in grants; 40% for state humanities councils and 60% for direct grants.
- National Science Foundation: $75M for research and related activities. The Senate summary of the bill adds additional context, stating that this funding will “support research at molecular, cellular, physiological and ecological levels to better understand coronavirus genetics, modes of action, transmission, virulence and population dynamics.”
COMMERCIAL SOLUTION OPENING
Air Force Acquisition COVID-19 Task Force (DAF ACT)
On April 6, the Air Force Acquisition COVID-19 Task Force issued a solicitation for new technologies to address seven mission areas: combating the COVID-19 spread; welfare of citizens; readiness; logistics; industrial base impacts; medical and other areas that support the national response to the pandemic.
Due date: 9/30/20
BARDA Broad Agency Announcement
BARDA is soliciting proposals for the advanced research and development of medical countermeasures under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003).
Proposals submitted under this BAA must focus on research and development activities that relate to specific areas of interest, consisting of medical countermeasures for chemical, biological, radiological and nuclear threats; pandemic influenza; and emerging infectious diseases. The BARDA BAA does not support the acquisition of products or the construction of facilities. BARDA anticipates that the research and development activities supported under the BAA will serve to advance candidate medical countermeasures toward licensure or approval by the FDA.
View the BARDA Broad Agency Announcement
Medical Technology Enterprise Consortium (MTEC) Solicitation Number: MTEC-20-09-COVID-19_Treatment_MIDRP
“Development of Treatments for COVID-19”
FOCUS AREA: Therapeutic(s) that can treat COVID-19. Treatments with potential application to the prevention of COVID-19 infection are desired. Therapeutics that can be administered in a non-hospital environment are desired.
AHA Rapid Response Grant COVID-19 and Its Cardiovascular Impact
To address this need, the American Heart Association (AHA) invites cardiovascular-focused applications that will contribute to understanding the cardiovascular and cerebrovascular pathogenesis, diagnosis, prevention, clinical manifestations, clinical management (including critical care management) and social behaviors which can lead to dissemination, containment, and complications of COVID-19. Because of the urgency of this issue, innovative, highly impactful short-term proposals (9-12 months), which can show progress within the period of this award, are sought.
Grant amounts will be up to $100,000, including up to 10 percent institutional indirect costs. The AHA anticipates funding at least 10 awards and a nationwide Coordinating Center.
Visit the Opportunity Source
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)
NIAID and NIGMS are issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.
NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.
British Society for Antimicrobial Chemotherapy (BASC) COVID-19 Funding Call
Grants of up to £25,000 to support research projects. Exceptional grants in excess of £25,000 will be considered. The funding scope covers: new projects, extension of existing research Projects, expenditure of staff and/or consumables.
Applications are open worldwide to all organizations and will be subject to a rapid peer review process. Research findings will be considered for fast track open access online publication in JAC or JAC-AMR.
Letter of Interest due: 4/17/20
Peace First Rapid Response Grants to address COVID-19
Peace First is launching a rapid response grant process to help young people around the world lead projects that address community impacts of COVID-19, from providing meals to elderly neighbors to launching digital mental health campaigns to support youth feeling isolated. Rapid response grants are open to young people between the ages of 13-25, anywhere in the world, starting today.
Due date:
Biological Technologies Office – DOD/DARPA
The mission of BTO is to foster, demonstrate, and transition breakthrough fundamental research, discoveries, and applications that integrate biology, engineering, computer science, mathematics, and the physical sciences. BTO’s investment portfolio goes far beyond life sciences applications in medicine to include areas of research such as human-machine interfaces, microbes as production platforms, and deep exploration of the impact of evolving ecologies and environments on U.S. readiness and capabilities. BTO’s programs operate across a wide range of scales, from individual cells to the warfighter to global ecosystems. BTO responds to the urgent and long-term needs of the Department of Defense (DoD) and addresses national security priorities.
Due Date: 4/23/20
DSO Office-wide Broad Agency Announcement – DOD/DARPA
The mission of the Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is to identify and create the next generation of scientific discovery by pursuing high-risk, high-payoff research initiatives across a broad spectrum of science and engineering disciplines and transforming these initiatives into disruptive technologies for U.S. national security. In support of this mission, the DSO Office-wide BAA invites proposers to submit innovative basic or applied research concepts that address one or more of the following technical domains: (1) Frontiers in Math, Computation and Design, (2) Limits of Sensing and Sensors, (3) Complex Social Systems, and (4) Anticipating Surprise. Each of these domains is described below and includes a list of example research topics that highlight several (but not all) potential areas of interest. Proposals must investigate innovative approaches that enable revolutionary advances. DSO is explicitly not interested in approaches or technologies that primarily result in evolutionary improvements to the existing state of practice.
Due Date: 6/12/20
CoV Pandemic Response – MCDC
The purpose of this special notice is to obtain information via White Papers from both MCDC members and other interested industry/academia partners in response to the novel Coronavirus (2019-nCoV) pandemic in the United States (U.S.). The Government is requesting White Papers with a focus on the following areas:
- Diagnostics/Monitoring: Medical diagnostic devices, with specific emphasis on Point-of-Care diagnostics (e.g. CLIA waived), under development and capable of diagnosing 2019- SARS-CoV-2, and achieving Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) within the next one to four (1-4) months.
- Surveillance: Surveillance methods and associated devices for 2019-SARS-CoV-2 screening. Any technology that can enhance the understanding of disease progression in COVID-19 infected patients is also of interest, including physiologic monitoring and other vital signs indicators, portable technology that enhances patient care in non-hospital settings, and technology that improves sample collection.
- Information systems and technology the Government can use in a handheld Point-of-Care device to collect, screen, collate, report, and monitor disease infection and pandemic spread on a micro and macro level.
- Therapeutics: Drugs and/or drug/device combinations, or platforms currently under development demonstrating efficacy in post-exposure, pre- and post-symptomatic studies for any CoV strain, and capable of achieving EUA from the FDA within the next three (3) months for this ongoing SARS-CoV-2 pandemic. Antibody technologies, accelerating the discovery, development, manufacturing, and prediction of success for these technologies, can also be considered.
- Prophylactics: Drugs or vaccines currently under development demonstrating pre-exposure in vivo efficacy or in vitro activity against any or all strains of CoV. Antibody technology, accelerating the discovery, development, manufacturing and prediction of success for these technologies can be considered.
- Clinical Trials: Opportunities to expeditiously conduct clinical trials for any technology that will require evaluation for FDA approval, will be considered.
Due Date 5/31/20
Visit the Opportunity Source
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV) – NIAID/NIGMS – NIH
NIAID and NIGMS are issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (2019-nCoV). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against 2019-nCoV.
NIGMS is specifically interested in incorporation of data from the 2019-nCoV into ongoing research efforts to develop predictive models for the spread of Coronaviruses and related pathogens.
Due Date: 4/8/20
Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for milestone-driven projects focused on preclinical development of lead candidate therapeutics, vaccines and related countermeasures against select NIAID Emerging Infectious Diseases/Pathogens. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant.
Due Date: 6/29/20
Notice of Special Interest (NOSI): Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)
NHLBI is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on Coronavirus Disease 2019 (COVID-19) and on biological effects of its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Topics of specific interest to NHLBI include host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.
Due Date: 3/17/20 – 10/06/20
Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus
NIDA is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 Novel Coronavirus (2019-nCoV, also known as COVID-19). NIDA is especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.
Due Date: 3/19/20 – 3/31/21
Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19).
Due Date: 3/25/20 – 2/6/21
Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. NCATS is soliciting applications for Administrative Supplements to UL1, U01, and R21 awards (through PA-18-591), Collaborative Innovation Awards to U01 and R21 awards (through PAR-19-099 and PAR-19-100, respectively), and Competitive Revisions for UL1 awards for each of the non-administrative supplement awards (through PAR-19-337).
Due Date: 5/4/20 – 6/10-21
NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
NIAID is taking several approaches to support new research in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 2019 (COVID-2019).
Due Date: 2/6/20 – 2/6/21
Centers for Disease Control COVID-19 Broad Agency Announcement
The Centers for Disease Control and Prevention is issuing Broad Agency Announcement (BAA) number 75D301-20-R-67897. The NAICS code for this BAA is 541705, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology and Nanotechnology) with a size standard of 1,000 employees. This BAA is open and in effect for 14 days from the date of issuance (March 11, 2020 through March 25, 2020). THIS IS AN IMMEDIATE CALL FOR WHITE PAPERS. Prior to submission of a white paper, offerors are strongly encouraged to contact the CDC BAA technical point of contact for the research topic/subtopic of interest. White papers must be received electronically by 3:00PM EST on March 25, 2020 in order to be considered for further evaluation. White papers should be submitted electronically to Jan Gum at tzg7@cdc.gov.
Due Date: 3/25/20 – ?
Centers for Disease Control COVID-19 Broad Agency Announcement
The purpose of amendment 00001 is to accomplish the following:
- Provide an update regarding official proposal submissions.
After reviewing white paper submissions, those offerors with favorable white papers will receive an official Request for Proposal from the Government. When submitting a proposal, offerors should adhere to the directions below:
The electronic copy must be in a format compatible with Microsoft Office 2016. The Government is NOT requiring a hard copy proposal submission. The electronic proposal shall be the official proposal and must be received by the submission date and time identified in the official Request for Proposal. The Government will also identify the email address required for proposal submittal in the official Request for Proposal.
Due Date: 3/25/20 – ?
Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health CDC-RFA-OT18-18020202SUPP20
Note: Funding is only available for the organizations that were previously awarded funding under Funding Strategy 1 of CDC-RFA-OT18-1802: “Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health” in FY18.
Due Date: 4/2/2020
Epidemic Preparedness: COVID-19 funding call
This call aims to strengthen the evidence base to better prevent and control coronavirus (COVID-19) epidemics and to increase research and response capacity.
It’s part of an existing partnership between Wellcome and the UK Department for International Development (DFID) through the Joint Initiative on Research in Epidemic Preparedness and Response to help low- and middle-income countries prepare for and tackle epidemics.
Due Date: Reviews pending
AWS Diagnostic Development Initiative (DDI)
The AWS Diagnostic Development Initiative (DDI) provides support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Although vaccine and treatment development research is generally funded by private foundations and government agencies, fast and reliable diagnostic techniques are slow to be developed. Accurate testing and diagnosis at point-of-care or regional locations for patients with COVID-19 is critical to early intervention and treatment. AWS is offering technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies.
Due Date: Currently Open
MIT Solve Health Security & Pandemics Challenge
MIT Solve is seeking tech innovations that can slow and track the spread of an emerging outbreak, for example by improving individual hygiene, developing low-cost rapid diagnostics, analyzing data that informs decision making, and providing tools that support and protect health workers.
Due Date: 6/18/2020
Michelson 20MM Support in Response to COVID-19
COVID-19 is creating new challenges across institutions of higher education. Michelson 29MM is committed to helping colleges during this uncertain time. They will also be issuing a new Spark Grants call for proposals, and hosting a series of webinars. Sign up to stay up to date about our COVID-19 work.
Due Date: 4/20/2020
Visit the Opportunity Source